Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-02-24 @ 5:03 PM
Study NCT ID:
NCT01833520
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2013-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-12
First Submit QC Date:
None
Study First Post Date:
2013-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-08
Results First Submit QC Date:
None
Results First Post Date:
2021-02-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-13
Last Update Post Date:
2021-02-02
Last Update Post Date Type:
ACTUAL